STAGE IIIA BREAST CANCER AJCC V7
Clinical trials for STAGE IIIA BREAST CANCER AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIIA BREAST CANCER AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE IIIA BREAST CANCER AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy shows promise for Hard-to-Treat cancers with specific gene mutations
Disease control OngoingThis study tested the drug pembrolizumab (a type of immunotherapy) in 21 adults with advanced solid tumors that have specific gene mutations (BRCA1, BRCA2, POLE, or POLD1). The goal was to see if the drug could shrink or control the cancer. Participants received pembrolizumab int…
Matched conditions: STAGE IIIA BREAST CANCER AJCC V7
Phase: PHASE2 • Sponsor: Rutgers, The State University of New Jersey • Aim: Disease control
Last updated Apr 29, 2026 05:16 UTC
-
Lifestyle makeover may boost breast cancer treatment
Disease control OngoingThis study tests whether a program of diet, exercise, stress management, and social support can improve outcomes for women with stage II or III breast cancer undergoing radiation therapy. About 110 participants will be randomly assigned to the lifestyle program or usual care. Res…
Matched conditions: STAGE IIIA BREAST CANCER AJCC V7
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 29, 2026 05:14 UTC
-
Shorter radiation may cut arm swelling in breast cancer patients
Symptom relief OngoingThis study compares a 3-week course of radiation to the standard 5-week course for people with invasive breast cancer who need radiation to the lymph nodes near the breast. The goal is to see if the shorter treatment reduces arm swelling (lymphedema) while keeping the cancer from…
Matched conditions: STAGE IIIA BREAST CANCER AJCC V7
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Apr 29, 2026 05:16 UTC